Live Breaking News & Updates on Erus

Stay informed with the latest breaking news from Erus on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Erus and stay connected to the pulse of your community

Cerus: FDA Approves 12-month Shelf Life For INTERCEPT Platelet Processing Sets

Cerus Corporation (CERS) announced the FDA has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture, effective immediately.

More-such-health-news , Cerus-corporation , Processing-sets , Fda , Erus ,

Merus (NASDAQ:MRUS) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, Merus...

How-well-is-merus , Meru-cash-burn , Free-cash-flow , Erus ,

3 patients die in cancer drug trial

Merus is studying a new antibody therapy for non-small cell lung cancer which has seen some success, however three patients have died

European-society-for-medical-oncology-asia-congress , European-society , Medical-oncology , Asia-congress , Lung-cancer , Erus , Cla-129 , Gfr , C-met , Linical-trial , Nterstitial-lung-disease

Merus Announces Publication of Abstracts on MCLA-129 for

- Oral presentation on MCLA-129 in combination with osimertinib as first line therapy, and in previously treated, NSCLC on Sunday, December 3 at 9:40 a.m....

Cambridge , Cambridgeshire , United-kingdom , Netherlands , Zenocutuzumab-zeno , European-society-for-medical-oncology , Early-access-program , Asia-congress , Development-strategy , Exchange-commission , Company-conference-call , European-society

How well-positioned is Stryker for 2024?

Stryker in 2023 has seen continued revenue growth and made progress with its spine portfolio.

Cerus-endovascular , Stryker , Evenue , Rowth , Pine , Ortfolio , Ako , Obot , Ayoffs , Erus ,

Positive week for Cerus Corporation (NASDAQ:CERS) institutional investors who lost 54% over the past year

Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...

William-greenman , Cerus-corporation , Investment-management , Nstitutional-ownership , Erus , Nstitutions , Nsider-ownership , Hare-registry ,

Merus Announces Business Update Conference Call

Zeno interim clinical data continues to show robust efficacy in NRG1+ NSCLC and PDAC: Sufficient clinical data expected in 1H24 to support potential BLA...

Cambridge , Cambridgeshire , United-kingdom , United-states , Netherlands , Madrid , Spain , American , Andrew-joe , Zenocutuzumab-zeno , Alison-schram , Early-access-program

Will Merus (NASDAQ:MRUS) Spend Its Cash Wisely?

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

How-well-is-merus , Meru-cash-burn , Free-cash-flow , Erus ,

Institutional investors may overlook Merus N.V.'s (NASDAQ:MRUS) recent US$113m market cap drop as long-term gains remain positive

Key Insights Significantly high institutional ownership implies Merus' stock price is sensitive to their trading...

Incyte-corporation , Public-company-ownership , Institutional-investors , Nstitutional-ownership , Erus , Erusnv- , Hareholders , Tock-price ,

Mark Herold Wines sells to Brion Wise

Napa winemaker Mark Herold has sold his namesake Cabernet brand to a familiar face.

Pritchard-hill , California , United-states , Berkeley , Napa-valley , Oakville , Carole-meredith , Paul-hobbs , Joseph-phelps , Fox-hill , Mark-herold , Lagier-meredith

Live Breaking News & Updates on Erus

Cerus Corporation (CERS) announced the FDA has granted approval of 12-month shelf life for INTERCEPT Platelet Processing Sets, from the date of manufacture, effective immediately.More-such-health-news , Cerus-corporation , Processing-sets , Fda , Erus ,

Just because a business does not make any money, does not mean that the stock will go down. For example, Merus...How-well-is-merus , Meru-cash-burn , Free-cash-flow , Erus ,

Stryker in 2023 has seen continued revenue growth and made progress with its spine portfolio.Cerus-endovascular , Stryker , Evenue , Rowth , Pine , Ortfolio , Ako , Obot , Ayoffs , Erus ,

Key Insights Significantly high institutional ownership implies Cerus' stock price is sensitive to their trading...William-greenman , Cerus-corporation , Investment-management , Nstitutional-ownership , Erus , Nstitutions , Nsider-ownership , Hare-registry ,

Just because a business does not make any money, does not mean that the stock will go down. For example, although...How-well-is-merus , Meru-cash-burn , Free-cash-flow , Erus ,

Key Insights Significantly high institutional ownership implies Merus' stock price is sensitive to their trading...Incyte-corporation , Public-company-ownership , Institutional-investors , Nstitutional-ownership , Erus , Erusnv- , Hareholders , Tock-price ,

Napa winemaker Mark Herold has sold his namesake Cabernet brand to a familiar face.Pritchard-hill , California , United-states , Berkeley , Napa-valley , Oakville , Carole-meredith , Paul-hobbs , Joseph-phelps , Fox-hill , Mark-herold , Lagier-meredith